Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.24.1.1.u2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net Sales $ 1,775 $ 4,190
Cost of Sales 2,177 3,435
Gross profit (loss) (402) 755
Operating Expenses    
Sales and marketing 231 333
Research and development 220 346
General and administrative 1,126 1,111
Total operating expenses 1,577 1,790
Loss from operations (1,979) (1,035)
Other income (expenses)    
Interest expense and finance costs (163) (78)
Total other income (expenses), net (163) (78)
Net loss $ (2,142) $ (1,113)
Net loss per share, basic $ (0.12) $ (0.09)
Net loss per share, diluted $ (0.12) $ (0.09)
Weighted average shares outstanding, basic 17,561,612 12,949,550
Weighted average shares outstanding, diluted 17,561,612 12,949,550